Types of Melanoma Research Funding

The 2014 grant acceptance period has now closed and applications are under review.

The MRF is proud to offer research award funding to senior investigators, junior investigators and medical students. Learn how to apply for a MRF research grant.

Below are the types of awards that will be funded in 2014:

Career Development Awards (CDA)

The CDAs provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career emphasizing melanoma-related projects and have not yet established strong federal funding for their research are eligible. The use of relevant genetic models and human derived tumor samples is highly encouraged. CDA applications may be part of the STP mechanism listed below.

Career Development Award for Mucosal Melanoma (CDA-MM)

This award will provide funding of up to $50,000 per year for two years to junior investigators focusing on mucosal melanoma. Researchers who are beginning a research career emphasizing melanoma-related projects and have not yet established strong federal funding for their research are eligible. The use of relevant genetic models and human derived tumor samples is highly encouraged.

Established Investigator Awards (EIA)

The EIA’s provide funding of up to $100,000 per year for two years to established melanoma researchers, or senior researchers working in closely related fields who wish to move into melanoma research. The use of relevant genetic models and human derived tumor samples is highly encouraged. EIA applications may be part of the newly established STP mechanism listed below.

Specific Topic Proposals (STP)

New for 2014 is the identification of scientific topics that address unmet clinical needs in melanoma research, which were identified through a series of meetings of multidisciplinary experts from the MRF Scientific Advisory Board and Breakthrough Consortium (see details below). Applicants are encouraged to address these questions in their proposed applications. The STPs provide funding between $100,000 (expected level of funding to individual established investigator) and $250,000 (expected level of funding to small teams of researchers) per award, per year, for two years. A minimum of 2 team based STPs are expected to be funded in 2014. The use of relevant genetic models and human derived tumor samples is highly encouraged. STP applications must address one of the 6 highlighted topics listed below. STP applications should demonstrate how the proposed studies will answer the unmet need. Applicants that are proposing a team effort must demonstrate the respective contribution of each researcher for the team effort.

The unmet needs in melanoma research selected for STPs in 2014 are:

  • Prevention: Development of models and biomarkers
  • Identifying mechanisms and respective therapeutic strategies in less common molecular subsets of melanoma
  • Metastases: Dormancy and metastatic progression
  • CNS Metastases: Development of markers of risk and rational therapeutic approaches
  • Response to treatment: Mechanisms and respective biomarkers for predictive and for monitoring therapeutic response
  • Resistance: Intrinsic/innate/primary resistance to immunotherapies in melanoma

For a full description of each of the STPs, please view the full 2014 RFP. Applicants are encouraged to focus on one of these themes in their proposed applications and clearly indicate which of the questions is being addressed.

Medical Student Awards

The Medical Student Awards provide funding of up to $3,000 per year for one year to medical students and are currently under review for the 2014 grant cycle. Applications for the Medical Student Awards are accepted from September 1 - November 1 of each previous year for the following grant cycle.

 

All questions regarding the grant program can be directed to the Program Director at research@melanoma.org.